Because clinical studies have indicated that SAR1B mutations affect chylomicron secretion and, despite intestinal fat malabsorption, some children with CMRD develop fatty liver (2, 16, –, 18), we examined relative SAR1A and SAR1B mRNA levels in human intestinal biopsies and liver samples. This evidence concerns the gene SAR1A and Hepatic steatosis.